TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE

Clinical trials for TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE explained in plain language.

Never miss a new study

Get alerted when new TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE trials appear

Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cannabis-Derived drug tested for brain symptoms in rare genetic disorder

Symptom relief Ongoing

This study is checking if adding the prescription CBD medication Epidiolex to existing anti-seizure drugs helps improve behavior problems, sleep, and quality of life in people with tuberous sclerosis complex (TSC). It will include up to 79 participants, aged 1 to 65, who have TSC…

Matched conditions: TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE

Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief

Last updated Mar 11, 2026 14:53 UTC

TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE

Get alerted when new TUBEROUS SCLEROSIS COMPLEX ASSOCIATED NEUROPSYCHIATRIC DISEASE trials appear

Cannabis-Derived drug tested for brain symptoms in rare genetic disorder